
|Articles|December 15, 2002
EMGT finds lower IOP delays progression
Malm?weden-The initial results of the Early Manifest Glaucoma Trial (EMGT), a National Eye Institute-sponsored study conducted in Sweden, suggest that IOP-lowering treatment significantly delays progression of open-angle glaucoma in patients with elevated and normal IOP.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Pickleball, fireworks, eyecare in space, and IRIS registry data among lead stories from day 1 of AAO 2025
2
Preclinical study suggests synaptic regeneration may offer new pathway to treat glaucoma
3
AAO 2025: The outcomes of the VERONA and DAVIO-2 studies set up continued phase 3 research
4
Tensions rise between STAAR and Broadwood as proposed Alcon deal nears vote
5